Significant Ownership of INTRACOASTAL CAPITAL, LLC

Large-stake snapshot 1 signal
Large-stake filing summary
  • Recent SEC Schedule 13D/G filings for INTRACOASTAL CAPITAL, LLC focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
/s/ Mitchell P. Kopin - Mitchell P. Kopin, Manager
Manager location
Delray Beach, FL

Follow Filing Activity

Follow INTRACOASTAL CAPITAL, LLC with Pro and return when a new Schedule 13D/G filing changes the record on this page.

Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.

Review Pro alert access Already have an account? Sign in and return here

Significant Ownership of INTRACOASTAL CAPITAL, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PPBT Purple Biotech Ltd. Ordinary shares, no par value per share 10% $124,305,955 +$36,106,330 282,513,535 +41% Mitchell P. Kopin 31 Mar 2026
UOKA MDJM LTD Class A ordinary shares, par value $0.025 per share 10% $1,146,062 548,355 Mitchell P. Kopin 11 Feb 2026
GOVX GeoVax Labs, Inc. Common stock, par value $0.001 per share 10% $821,856 +$334,618 4,806,174 +69% Mitchell P. Kopin 31 Dec 2025
LUCY Innovative Eyewear, Inc. Common stock, par value $0.00001 per share 10% $776,217 +$117,095 699,295 +18% Mitchell P. Kopin 31 Mar 2026
SBFM Sunshine Biopharma Inc. Common stock, par value $0.001 per share 10% $702,858 505,653 Mitchell P. Kopin 19 May 2025
PCSA Processa Pharmaceuticals, Inc. Common stock, par value $0.0001 per share 10% $668,668 -$25,527 2,907,250 -3.7% Mitchell P. Kopin 30 Jun 2025
SILO Silo Pharma, Inc. Common stock, par value $0.0001 per share 10% $661,378 125,261 Mitchell P. Kopin 30 Jun 2026
APDN Applied DNA Sciences, Inc. Common Stock, par value $0.001 per share 10% $603,445 143,336 Mitchell P. Kopin 08 Jul 2025
SILO Silo Pharma, Inc. Common stock, par value $0.0001 per share 10% $561,702 +$35,627 1,478,164 +6.8% Mitchell P. Kopin 31 Dec 2025
SBFM Sunshine Biopharma Inc. Common stock, par value $0.001 per share 10% $504,392 235,697 Mitchell P. Kopin 30 Jun 2026
BBLG Bone Biologics Corporation Common stock, par value $0.001 per share 10% $482,187 +$111,397 199,251 +30% Mitchell P. Kopin 30 Sep 2025
ICU SeaStar Medical Holding Corporation Common stock, par value $0.0001 per share 10% $106,381 -$848,979 443,253 -89% Mitchell P. Kopin 31 Mar 2026
ARTL Artelo Biosciences, Inc. Common Stock, par value $0.001 per share 10% $98,041 81,701 Mitchell P. Kopin 30 Mar 2026
BJDX Bluejay Diagnostics, Inc. Common stock, par value $0.0001 per share 10% $0 0 Mitchell P. Kopin 03 Jun 2026
BLCM GeoVax Labs, Inc. Common stock, par value $0.001 per share 10% 233,337 Mitchell P. Kopin 31 Mar 2026
PMCB PharmaCyte Biotech, Inc. Common Stock, $0.0001 par value per share 10% 695,715 -2.7% Mitchell P. Kopin 30 Sep 2025
NCPL Netcapital Inc. Common stock, par value $0.001 per share 9.3% $1,194,239 +$509,092 501,781 +74% Mitchell P. Kopin 30 Sep 2025
PHIO Phio Pharmaceuticals Corp. Common stock, par value $0.0001 per share 9.1% $1,348,216 +$840,816 1,142,556 +166% Mitchell P. Kopin 31 Dec 2025
SXTP 60 Degrees Pharmaceuticals, Inc. Common stock, par value $0.0001 per share 9.1% $339,474 -$248,179 263,158 -42% Mitchell P. Kopin 31 Mar 2026
LGVN Longeveron Inc. Class A Common Stock, par value $0.001 per share 9% $1,911,767 +$518,545 2,941,180 +37% Mitchell P. Kopin 30 Jun 2026
MBOT Microbot Medical Inc. Common stock, par value $0.01 per share 8.2% $12,004,370 +$12,004,370 6,002,185 Mitchell P. Kopin 15 Jan 2026
LMFA PowerCompute, Inc. Common Stock, par value $0.001 per share 8.2% $4,530,643 1,551,590 Mitchell P. Kopin 30 Jun 2026
PCSA Processa Pharmaceuticals, Inc. Common stock, par value $0.0001 per share 8.1% $644,000 200,000 Mitchell P. Kopin 31 Dec 2025
AEMD Aethlon Medical, Inc. Common Stock, par value $0.001 per share 7.7% $714,988 576,603 Mitchell P. Kopin 04 Sep 2025
LMFA LM Funding America, Inc. Common Stock, par value $0.001 per share 7.6% $1,119,559 +$730,336 1,166,207 +188% Mitchell P. Kopin 19 Dec 2025
ELPW Elong Power Holding Limited Class A ordinary shares, par value $0.0128 per share 7.4% $1,225,000 1,225,000 Mitchell P. Kopin 10 Jul 2026
CETX Cemtrex Inc. Common stock, par value $0.001 per share 7.3% $248,055 +$214,427 605,011 +638% Mitchell P. Kopin 31 Dec 2025
NAYA NAYA Biosciences Inc. Common stock, par value $0.0001 per share 6.9% $166,478 504,478 Mitchell P. Kopin 12 Jan 2025
GRI GRI Bio, Inc. Common stock, par value $0.0001 per share 5.9% $18,095 -$201,477 90,475 -92% Mitchell P. Kopin 31 Mar 2026
SOBR SOBR Safe, Inc. Common stock, par value $0.00001 per share 5.6% $229,000 +$59,064 254,445 +35% Mitchell P. Kopin 15 Jul 2026
SVRE SaverOne 2014 Ltd. Ordinary shares, par value NIS 0.01 per share 5% $11,347,045 35,459,516 Mitchell P. Kopin 30 Jan 2025
BLRX BioLineRx Ltd. Ordinary shares, par value NIS 0.10 per share 5% $11,245,973 102,236,115 Mitchell P. Kopin 06 Jan 2025
DPRO Draganfly Inc. Common shares, no par value per share 5% $3,139,023 +$1,014,635 990,228 +48% Mitchell P. Kopin 17 Jul 2025
MBRX Moleculin Biotech, Inc. Common stock, par value $0.001 per share 5% $2,152,379 973,927 Mitchell P. Kopin 31 Jul 2026
BNGO Bionano Genomics, Inc. Common Stock, par value $0.0001 per share 5% $1,957,398 508,415 Mitchell P. Kopin 16 Sep 2025
ASTI Ascent Solar Technologies, Inc. Common stock, par value $0.0001 per share 5% $1,803,910 +$79,239 496,945 +4.6% Mitchell P. Kopin 31 Mar 2026
LIMN Liminatus Pharma, Inc. Common Stock, par value $ 0.0001 per share 5% $1,487,437 2,065,885 Mitchell P. Kopin 17 Feb 2026
SNGX Soligenix, Inc. Common Stock, par value $0.001 per share 5% $1,241,014 446,408 Mitchell P. Kopin 25 Sep 2025
OTLK Outlook Therapeutics, Inc Common Stock, par value $0.01 per share 5% $1,232,834 5,990,447 Mitchell P. Kopin 22 Apr 2026
BCDA BioCardia, Inc. Common Stock, par value $0.001 per share 5% $1,086,499 557,179 Mitchell P. Kopin 18 Sep 2025
JZXN Jiuzi Holdings Inc. Ordinary shares, par value $0.00039 per share 5% $1,083,753 1,062,503 Mitchell P. Kopin 29 Sep 2025
VVOS Vivos Therapeutics Inc. Common stock, par value $0.0001 per share 5% $796,804 297,315 Mitchell P. Kopin 22 Dec 2024
JAGX Jaguar Health, Inc. Common stock, par value $0.0001 per share 5% $779,374 65,002 Mitchell P. Kopin 20 May 2025
DFSC DEFSEC Technologies Inc. Common shares, no par value per share 5% $777,869 71,693 Mitchell P. Kopin 23 Jul 2025
SLRX Salarius Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 5% $711,721 187,295 Mitchell P. Kopin 12 Nov 2025
IMNN Imunon, Inc. Common stock, par value $0.01 per share 5% $650,990 -$26,789 1,067,196 -4% Mitchell P. Kopin 30 Jun 2025
GXAI GAXOS.AI INC. Common stock, par value $0.0001 per share 5% $577,824 +$286,924 722,280 +99% Mitchell P. Kopin 14 Aug 2026
TNON Tenon Medical, Inc. Common stock, par value $0.001 per share 5% $565,812 912,600 Mitchell P. Kopin 29 Jun 2026
IVDA Iveda Solutions, Inc. Common Stock, par value $0.00001 per share 5% $538,897 592,195 Mitchell P. Kopin 09 Feb 2026
KTTA Pasithea Therapeutics Corp. Common stock, par value $0.0001 per share 5% $537,188 317,863 Mitchell P. Kopin 06 May 2025
MBIO Mustang Bio, Inc Common stock, par value $0.0001 per share 5% $491,647 -$134,951 185,527 -22% Mitchell P. Kopin 30 Jun 2025
PMCB PharmaCyte Biotech, Inc. Common Stock, $0.0001 par value per share 5% $484,351 532,254 Mitchell P. Kopin 31 Dec 2025
RELI Reliance Global Group, Inc. Common Stock, par value $0.086 per share 5% $477,865 942,906 Mitchell P. Kopin 28 Jan 2026
GOVX GeoVax Labs, Inc. Common stock, par value $0.001 per share 5% $325,652 273,657 Mitchell P. Kopin 30 Jun 2026
AMST Amesite Inc. Common Stock, par value $0.0001 per share 5% $311,190 293,575 Mitchell P. Kopin 27 Apr 2026
VERO Venus Concept Inc. Common stock, par value $0.0001 per share 5% $299,980 +$205,918 120,474 +219% Mitchell P. Kopin 06 Jun 2025
MI NFT Limited Class A ordinary shares, par value $0.04 per share 5% $294,097 28,333 Mitchell P. Kopin 21 Aug 2026
ENVB Enveric Biosciences, Inc. Common Stock, par value $0.01 per share 5% $278,572 +$155,982 71,246 +127% Mitchell P. Kopin 27 Jan 2026
SLXN Silexion Therapeutics Corp Ordinary shares, par value $0.0009 per share 5% $195,139 209,827 Mitchell P. Kopin 15 Jan 2025
LIXT Lixte Biotechnology Holdings, Inc. Common stock, par value $0.0001 per share 5% $181,780 138,763 Mitchell P. Kopin 11 Feb 2025
ALBT Change Agents Corporation. Common Stock, par value $0.0001 per share 5% $164,516 +$37,064 632,752 +29% Mitchell P. Kopin 30 Jun 2026
GRI GRI Bio, Inc. Common stock, par value $0.0001 per share 5% $150,668 93,005 Mitchell P. Kopin 30 Jun 2026
ATNF 180 Life Sciences Corp. Common stock, par value $0.0001 per share 5% $148,764 165,293 Mitchell P. Kopin 27 Dec 2024
DRMA Dermata Therapeutics, Inc. Common stock, par value $0.0001 per share 5% $147,872 +$44,931 211,246 +44% Mitchell P. Kopin 31 Mar 2026
SLXN Silexion Therapeutics Corp Ordinary shares, par value $0.135 per share 5% $120,484 -$16,016 286,866 -12% Mitchell P. Kopin 11 Aug 2026
BJDX Bluejay Diagnostics, Inc. Common Stock, par value $0.0001 per share 5% $59,499 -$55,928 91,537 -48% Mitchell P. Kopin 31 Dec 2025
IVF INVO Fertility, Inc. Common stock, par value $0.0001 per share 5% $56,319 34,981 Mitchell P. Kopin 31 Mar 2025
SOBR SOBR Safe, Inc. Common stock, par value $0.00001 per share 5% $42,599 99,067 Mitchell P. Kopin 31 Mar 2026
CLRB Cellectar Biosciences, Inc. Common stock, par value $0.00001 per share 5% 140,101 Mitchell P. Kopin 01 Jul 2025
LFWD Lifeward Ltd. Ordinary Shares, par value NIS 1.75 per share 5% 819,443 +48% Mitchell P. Kopin 25 Jun 2025
GNPX Genprex, Inc. Common Stock, par value $0.001 per share 5% 84,814 Mitchell P. Kopin 28 Oct 2025
ARTL Artelo Biosciences, Inc. Common Stock, par value $0.001 per share 4.8% $187,827 173,914 Mitchell P. Kopin 30 Jun 2026
AREB American Rebel Holdings, Inc. Common stock, par value $0.001 per share 4.7% $463,382 +$269,714 335,784 +139% Mitchell P. Kopin 30 Jun 2025
NUWE Nuwellis, Inc. Common stock, par value $0.0001 per share 4.7% $34,218 -$21,021 155,536 -38% Mitchell P. Kopin 31 Jul 2026
BRTX BioRestorative Therapies, Inc. Common Stock, par value $0.0001 per share 4.1% $1,051,243 922,143 Mitchell P. Kopin 11 Feb 2026
ASNS Actelis Networks, Inc. Common stock, par value $0.0001 per share 4% $358,049 +$86,113 1,118,903 +32% Mitchell P. Kopin 31 Mar 2026
ADD Zeta Network Group Class A Ordinary Shares, par value $0.0001 per share 3.7% $908,669 -$376,105 1,094,782 -29% Mitchell P. Kopin 13 Aug 2025
CETX Cemtrex Inc. Common stock, par value $0.001 per share 3.5% $984,873 398,734 Mitchell P. Kopin 30 Jun 2026
ADIL Adial Pharmaceuticals, Inc. Common stock, par value $0.001 per share 2.8% $325,786 446,282 Mitchell P. Kopin 17 Jun 2025
TIRXF TIAN RUIXIANG Holdings Ltd Class A ordinary shares, par value $0.125 per share 2.4% $20,107 -$80,899 2,010,733 -80% Mitchell P. Kopin 31 Mar 2026
AETHLON MEDICAL INC Common Stock, par value $0.001 per share 2.3% 55,556 Mitchell P. Kopin 30 Jun 2026
ENVB Enveric Biosciences, Inc. Common Stock, par value $0.01 per share 0.4% $28,033 -$122,696 19,333 -81% Mitchell P. Kopin 18 Sep 2025
AIM AIM ImmunoTech Inc. Common stock, par value $0.001 per share 0% $0 0 Mitchell P. Kopin 20 May 2026
SLXNW Silexion Therapeutics Corp Ordinary shares, par value $0.135 per share 0% $0 0 Mitchell P. Kopin 30 Jun 2026
APVO Aptevo Therapeutics Inc. Common stock, par value $0.001 per share 0% $0 0 Mitchell P. Kopin 18 Jun 2025
DATS DatChat, Inc. Common stock, par value $0.0001 per share 0% $0 0 Mitchell P. Kopin 08 Jan 2025
SLNH Soluna Holdings, Inc. Common stock, par value $0.001 per share 0% $0 -$7,044,795 0 -100% Mitchell P. Kopin 30 Sep 2025

Schedules 13D/G Reported by INTRACOASTAL CAPITAL, LLC:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .